Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Biomedicines|May 27, 2023
Acute Kidney Injury in Hospitalized Patients with COVID-19: Risk Factors and Serum BiomarkersAnastasia Shchepalina, Natalia Chebotareva, Larissa Akulkina, et al.
International Journal of Molecular Sciences|October 27, 2022
Potential Urine Proteomic Biomarkers for Focal Segmental Glomerulosclerosis and Minimal Change DiseaseNatalia V Chebotareva, Anatoliy Vinogradov, Alexander G Brzhozovskiy, et al.
Rheumatology (Oxford, England)|February 7, 2025
Predictors of response to intravenous immunoglobulin in patients with dermatomyositis: the ProDERM studyChristina Charles-Schoeman, Joachim Schessl, Zsuzsanna Bata-Csörgő, et al.
Rheumatology and Therapy|July 5, 2025
Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub-analysis of the ProDERM StudyRohit Aggarwal, Joachim Schessl, Zsuzsanna Bata-Csörgő, et al.
Molecules (Basel, Switzerland)|April 28, 2023
Targeted MRM Quantification of Urinary Proteins in Chronic Kidney Disease Caused by GlomerulopathiesAlexey S Kononikhin, Alexander G Brzhozovskiy, Anna E Bugrova, et al.
Arthritis Research & Therapy|January 17, 2024
Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM studyRohit Aggarwal, Joachim Schessl, Christina Charles-Schoeman, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 15, 2021
Induction and maintenance of remission with mycophenolate mofetil in ANCA-associated vasculitis: a systematic review and meta-analysisAlvise Berti, Mouaz Alsawas, Tabinda Jawaid, et al.
Nephron|June 12, 2026
Long-Term Therapy with Eculizumab Biosimilar in Patients with Atypical Haemolytic Uraemic Syndrome: Outcomes of a Prospective Observational StudyOleg Kotenko, Natalia Kozlovskaya, Khadizha Emirova, et al.
Scientific Reports|March 3, 2022
In hospital risk factors for acute kidney injury and its burden in patients with Sars-Cov-2 infection: a longitudinal multinational studyMario Luca Morieri, Claudio Ronco, Angelo Avogaro, et al.
Frontiers in Immunology|September 28, 2023
COVID-19 outcomes in patients with a history of immune-mediated glomerular diseasesPhilipp Gauckler, Jana S Kesenheimer, Duvuru Geetha, et al.
Pageof 6